Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Hormone or other secreted growth regulatory factor,...
Reexamination Certificate
2005-07-28
2009-08-04
Rao, Manjunath N (Department: 1647)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Hormone or other secreted growth regulatory factor,...
C514S012200, C514S002600, C530S350000, C435S001100
Reexamination Certificate
active
07569227
ABSTRACT:
The present invention is concerned with proteins selected from the members of the TGF-β superfamily, which are monomeric due to substitution or deletion of a cysteine which is responsible for dimer formation. The invention is also concerned with nucleic acids, encoding such monomeric proteins, vectors or host cells containing the nucleic acids as well as with pharmaceutical compositions comprising the proteins or nucleic acids encoding the proteins. The compositions can be applied advantageously for all indications for which the respective dimeric proteins are useful.
REFERENCES:
patent: 5801014 (1998-09-01), Lee et al.
patent: 0915168 (1999-05-01), None
patent: WO 94 17099 (1994-08-01), None
patent: WO 95 04819 (1995-02-01), None
patent: WO 95 16035 (1995-06-01), None
patent: WO 96 01316 (1996-01-01), None
patent: WO 97 03188 (1997-01-01), None
patent: WO 9961611 (1999-12-01), None
Sullivan et al. 1997. Neurosci Letters 233:73-76.
Bowie et al, 1990, Science 247:1306-1310.
Wells, 1990, Biochemistry 29:8509-8517.
Ngo et al., 1994, The Protein Folding Problem and Tertiary Structure Prediction, Merz et al., eds, Birkhauser, Boston, pp. 491-495.
Vukicevic et al. 1996, PNAS USA 93:9021-9026.
Sullivan et al. 2005. J. Anat. 207:219-226.
Pettit et al. Trends Biotechnol. 16:343-349.
Miller, G. 2002. Science 297:1116-1118.
Husken-Hind, Pertra et al., “Monomeric activin A retains high receptor binding affinity but exhibits low biological activity,”Journal of Biological Chemistry(1994), vol. 269, No. 30, pp. 19380-19384, Jul. 24, 1994.
Amatayakul-Chantler, Supavadee et al., “Selective biological activity and receptor binding in mink lung epithelial cells,”Journal of Biological Chemistry(1994), vol. 269, No. 44, pp. 27687-27691, Nov. 4, 1994.
Brunner, Amy M., “Site-directed mutagenesis of glycosylation sites in the transforming growth factor-beta-1,”Molecular Endocrinology(1992), vol. 6, No. 10, pp. 1691-1700.
Brunner, A.M. et al., “Sie-Directed Mutagenesis of Cysteine Residues in the Pro Region of the Transforming Growth Factor Beta-1 Precursor Expression and Characterization of Mutant Proteins,”J. Biol. Chem, 264 (23), 13660-13664, Aug. 15, 1989.
Daopin, S. et al., “Crystal Structure of Transforming Growth Factor-Beta2: UN Unusual Fold for the Superfamily,”Science, U.S., American Association for the Advancement of Science (1992), vol. 257, pp. 369-373.
Schlunegger, M.P. et al., “An unusual feature revealed by the crystal structure at 2.2 A resolution of human transforming growth factor-beta 2,”Nature, GB, MacMillan Journals Ltd., London, vol. 358, No. 358, pp. 430-434.
Wolfman, N. et al, Ectopic Induction of Tendon and Ligament in Rats by Growth and Differentation Factors 5, 6, and 7, Members of the TGF-β Geme Family,J. Clin. Invest.1997, vol. 100, pp. 321-300.
Bechtold Rolf
Hötten Gertrud
Pohl Jens
HyGene AG
Rao Manjunath N
Rothwell Figg Ernst & Manbeck P.C.
Shafer Shulamith H
LandOfFree
Monomeric protein of the TGF-β family does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monomeric protein of the TGF-β family, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monomeric protein of the TGF-β family will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4082310